Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
Active, not recruiting · NCT03172754 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-22 | NCT03172754 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fox Chase Cancer Center | 58 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cornell | New York | United States | 2 |
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| Johns Hopkins | Baltimore | United States | 7 |
| US Oncology and Hematology | Albany | United States | 1 |